These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22670805)

  • 1. LDL apheresis and inflammation--implications for atherosclerosis.
    Hovland A; Lappegård KT; Mollnes TE
    Scand J Immunol; 2012 Sep; 76(3):229-36. PubMed ID: 22670805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different inflammatory responses induced by three LDL-lowering apheresis columns.
    Hovland A; Hardersen R; Sexton J; Mollnes TE; Lappegård KT
    J Clin Apher; 2009; 24(6):247-53. PubMed ID: 19927364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of low-density lipoprotein apheresis on plasma levels of apolipoprotein e4.
    Moriarty PM; Luyendyk JP; Gibson CA; Backes JM
    Am J Cardiol; 2010 Jun; 105(11):1585-7. PubMed ID: 20494666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of low-density lipoprotein apheresis on inflammatory and noninflammatory high-density lipoprotein cholesterol.
    Opole IO; Belmont JM; Kumar A; Moriarty PM
    Am J Cardiol; 2007 Nov; 100(9):1416-8. PubMed ID: 17950800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of LDL-apheresis--more than reduction of cholesterol?].
    Schettler V; Wieland E
    Dtsch Med Wochenschr; 2007 Mar; 132(11):575-8. PubMed ID: 17342636
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One year experience with a low density lipoprotein apheresis system.
    Durst R; Rund D; Schurr D; Eliav O; Ben-Yehuda D; Shpizen S; Ben-Avi L; Schaap T; Pelz I; Leitersdorf E
    Isr Med Assoc J; 2002 Sep; 4(9):677-80. PubMed ID: 12440228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LDL-apheresis reduces P-Selectin, CRP and fibrinogen -- possible important implications for improving atherosclerosis.
    Kobayashi S; Oka M; Moriya H; Maesato K; Okamoto K; Ohtake T
    Ther Apher Dial; 2006 Jun; 10(3):219-23. PubMed ID: 16817784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement profile and activation mechanisms by different LDL apheresis systems.
    Hovland A; Hardersen R; Nielsen EW; Enebakk T; Christiansen D; Ludviksen JK; Mollnes TE; Lappegård KT
    Acta Biomater; 2012 Jul; 8(6):2288-96. PubMed ID: 22373816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two whole blood systems (DALI and Liposorber D) for LDL apheresis on lipids and cardiovascular risk markers in severe hypercholesterolemia.
    Otto C; Berster J; Otto B; Parhofer KG
    J Clin Apher; 2007; 22(6):301-5. PubMed ID: 17935245
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LDL-apheresis: clinical experience and indications in the treatment of severe hypercholesterolemia.
    Thiery J; Seidel D
    Transfus Sci; 1993 Jul; 14(3):249-59. PubMed ID: 10146336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins.
    Geiss HC; Otto C; Parhofer KG
    Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LDL apheresis activates the complement system and the cytokine network, whereas PCSK9 inhibition with evolocumab induces no inflammatory response.
    Lappegård KT; Enebakk T; Thunhaug H; Ludviksen JK; Mollnes TE; Hovland A
    J Clin Lipidol; 2016; 10(6):1481-1487. PubMed ID: 27919366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear stress-dependent platelet function after LDL cholesterol apheresis.
    Spieker LE; Ruschitzka F; Badimon JJ; Noll G; Corti R
    Thromb Res; 2004; 113(6):395-8. PubMed ID: 15226094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apheresis technologies for prevention and regression of atherosclerosis: clinical results.
    Bambauer R; Schneidewind JM; Latza R
    ASAIO J; 1999; 45(5):403-7. PubMed ID: 10503615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of different LDL apheresis methods.
    Julius U; Frind A; Tselmin S; Kopprasch S; Poberschin I; Siegert G
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):629-39. PubMed ID: 18510481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of homozygous familial hypercholesterolemia with LDL-apheresis on a 4-year-old child].
    Lefort B; Giraud C; Saulnier JP; Bott L; Gambert C; Sosner P; Hankard R
    Arch Pediatr; 2009 Dec; 16(12):1554-8. PubMed ID: 19766469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LDL cholesterol apheresis by adsorption to dextran sulfate].
    Grunewald RW; Ditschuneit HH; Klein J; König W; Grunewald JM; Franz HE
    Infusionsther Transfusionsmed; 1992 Aug; 19(4):194-6. PubMed ID: 1422078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of proteins eliminated by low-density lipoprotein apheresis.
    Yuasa Y; Osaki T; Makino H; Iwamoto N; Kishimoto I; Usami M; Minamino N; Harada-Shiba M
    Ther Apher Dial; 2014 Feb; 18(1):93-102. PubMed ID: 24499090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.